Microfluidic DNA-based potassium nanosensors for improved dialysis treatment

BACKGROUND: Patients with end-stage renal disease (ESRD) have failed kidney function, and often must be treated with hemodialysis to extend the patient’s life by artificially removing excess fluid and toxins from the blood. However, life-threatening treatment complications can occur because hemodial...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Alexander F., Zhao, Bin, You, Mingxu, Jiménez, Juan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558827/
https://www.ncbi.nlm.nih.gov/pubmed/31185982
http://dx.doi.org/10.1186/s12938-019-0692-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558827/
https://www.ncbi.nlm.nih.gov/pubmed/31185982
http://dx.doi.org/10.1186/s12938-019-0692-8

Ejemplares similares